Abstract
The hormone estradiol 17 beta valerate (E2V), used in hormone
replacement therapy, undergoes a structural phase transition at 251.1 K
on cooling. The crystalline structure of the low and room temperature
phases were determined showing that neither the space group nor the site
symmetry and number of atoms are altered. These phases are related by a
large conformational reorientation of the valerate chain. In addition,
thermal analysis, solid state nuclear magnetic resonance, and infrared
spectroscopy show that the transformation is reversible, discontinuous,
and first order, evidencing the occurence of an isosymmetric phase
transition, rare for organic compounds.
Users
Please
log in to take part in the discussion (add own reviews or comments).